financial statements
The full income statement, balance sheet, and cash-flow statement for Edwards Lifesciences Corporation (EW), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 6.07B YoY+11.5% | 5.44B YoY+8.6% | 5.01B YoY+12.2% | 4.46B YoY-14.7% | 5.23B YoY+19.3% | |
4.73B YoY+9.5% | 4.32B YoY+7.2% | 4.03B YoY+7.8% | 3.74B YoY-6.1% | 3.98B YoY+20.5% | ||
| Research & development | 1.08B YoY+2.5% | 1.05B YoY+9.4% | 963M YoY+14.1% | 844M YoY-6.6% | 903M YoY+18.7% | |
| Selling, general & administrative | 2.09B YoY+16.5% | 1.79B YoY+13.1% | 1.58B YoY+16.6% | 1.36B YoY-9.1% | 1.49B YoY+21.6% | |
| Restructuring | 13.1M YoY-60.2% | 32.9M | — | — | — | |
| Amortization of intangibles | 8.40M YoY+50.0% | 5.60M YoY+154.5% | 2.20M YoY-4.3% | 2.30M YoY-70.1% | 7.70M YoY+42.6% | |
| Operating income | 1.26B YoY-8.3% | 1.38B YoY+5.3% | 1.31B YoY-12.6% | 1.50B YoY-11.4% | 1.69B YoY+88.3% | |
| Interest expense | 20.4M YoY+3.0% | 19.8M YoY+12.5% | 17.6M YoY-8.3% | 19.2M YoY+4.3% | 18.4M YoY+16.5% | |
| Interest & investment income | 169M YoY+40.3% | 120M YoY+79.0% | 67.2M YoY+89.3% | 35.5M YoY+104.0% | 17.4M YoY-25.6% | |
| Net interest income | -20.4M YoY-3.0% | -19.8M YoY-12.5% | -17.6M | — | — | |
| Other non-operating income | 7.20M YoY-89.6% | 68.9M YoY+395.7% | 13.9M YoY+189.6% | 4.80M YoY-62.2% | 12.7M YoY+10.4% | |
| Pre-tax income | 1.27B YoY-17.8% | 1.55B YoY+12.8% | 1.37B YoY-9.7% | 1.52B YoY-10.7% | 1.70B YoY+85.7% | |
| Income tax | 217M YoY+42.6% | 152M YoY-0.2% | 152M YoY-22.0% | 196M YoY-1.7% | 199M YoY+113.2% | |
1.07B YoY-74.3% | 4.17B YoY+197.7% | 1.40B YoY-7.9% | 1.52B YoY+1.3% | 1.50B | ||
$1.83 YoY-73.7% | $6.97 YoY+203.0% | $2.30 YoY-5.7% | $2.44 YoY+2.5% | $2.38 YoY+83.1% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
6.74B YoY+7.2% | 6.29B YoY+55.7% | 4.04B YoY+30.4% | 3.10B YoY-2.7% | 3.18B YoY+2.9% | ||
13.7B YoY+4.9% | 13.1B YoY+39.4% | 9.36B YoY+12.9% | 8.29B YoY-2.5% | 8.50B YoY+17.5% | ||
1.81B YoY+20.5% | 1.51B YoY+25.9% | 1.20B YoY+16.9% | 1.02B YoY-1.0% | 1.03B YoY+15.5% | ||
3.36B YoY+12.3% | 2.99B YoY+13.2% | 2.64B YoY+6.4% | 2.49B YoY-6.8% | 2.67B YoY+0.1% | ||
10.3B YoY+3.4% | 10.00B YoY+50.4% | 6.65B YoY+14.5% | 5.81B YoY-0.5% | 5.84B YoY+27.6% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.60B YoY+194.2% | 542M YoY-39.5% | 896M YoY-26.5% | 1.22B YoY-29.7% | 1.73B YoY+64.3% | ||
-713M YoY-130.8% | 2.31B YoY+1230.8% | 174M YoY-31.1% | 252M YoY+114.6% | -1.72B YoY-224.3% | ||
-957M YoY+2.7% | -983M YoY-38.3% | -711M YoY+55.1% | -1.58B YoY-344.7% | -356M YoY+26.8% | ||
| FX effect on cash | -44.8M YoY-216.1% | 38.6M YoY+129.8% | 16.8M YoY-12.5% | 19.2M YoY+38.1% | 13.9M YoY+167.8% | |
| Net change in cash | -119M YoY-106.2% | 1.91B YoY+409.0% | 375M YoY+496.0% | -94.8M YoY+71.5% | -333M YoY-2206.3% | |
| Interest paid | 20.2M YoY+3.1% | 19.6M YoY-1.5% | 19.9M YoY+3.1% | 19.3M YoY-4.5% | 20.2M YoY+1.5% | |
| Income taxes paid | 490M YoY-59.0% | 1.20B YoY+154.4% | 470M YoY-6.7% | 504M YoY+176.2% | 183M YoY-7.8% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 49.5B YoY+13.3% | 43.7B YoY-5.6% | 46.2B YoY+0.3% | 46.1B YoY-43.0% | 80.9B YoY+42.3% | |
| P/E | 46.1× YoY+340.6% | 10.5× YoY-67.7% | 32.4× | — | — | |
| P/S | 8.2× YoY+1.6% | 8.0× YoY-27.7% | 11.1× YoY+28.8% | 8.6× YoY-44.2% | 15.5× YoY+19.2% | |
| P/B | 4.8× YoY+9.6% | 4.4× YoY-37.3% | 7.0× YoY-6.4% | 7.4× YoY-46.3% | 13.9× YoY+11.5% | |
| P/FCF | 37.1× YoY-75.4% | 150.6× YoY+162.7% | 57.3× YoY+29.4% | 44.3× YoY-22.9% | 57.5× YoY-34.5% | |
| Earnings yield | 2.2% YoY-77.3% | 9.6% YoY+209.7% | 3.1% | — | — | |
| FCF yield | 2.7% YoY+306.4% | 0.7% YoY-61.9% | 1.7% YoY-22.7% | 2.3% YoY+29.8% | 1.7% YoY+52.7% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: EW's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all EW filings on SEC EDGAR → Not investment advice.
